Aegon’s McPartlin: Three stocks driving the paradigm shift in healthcare
Exciting developments are underway in the healthcare world, and these three companies are leading that change
Exciting developments are underway in the healthcare world, and these three companies are leading that change
|
|
Mike Coop asks whether having exposure to the region is still worthwhile
|
|
Principal AM’s Foshag argues there’s a strong valuation argument for the sector
|
|
Wealth managers need to integrate AI, but it must be in a pragmatic and grounded way, says Mallowstreet’s Stu Breyer
|
|
Portfolio Adviser asks this month’s panel for their outlook on investing in renewable energy
|
|
Chinese growth has slowed, but it is far from over, says Polar Capital’s Jerry Wu
|
|
Sarasin & Partners portfolio manager and UK equity analyst discusses value of small caps
|
|
High yield bonds had a strong 2023 but the cracks are starting to show, writes FundCalibre’s Darius McDermott
|
|
Pessimism is rife in the UK, but Man Group’s Henry Dixon and Jack Barrat say it is worth challenging that widely-held mindset
|
|
Redwheel’s head of business development
|
|
Nicholas Price argues that Japan equity valuations are still undemanding
|
|
The world is diverging, and Latin American may be able to take advantage
|
|